S&P 500 Futures
(0.59%) 5 076.50 points
Dow Jones Futures
(0.34%) 38 199 points
Nasdaq Futures
(0.83%) 17 582 points
Oil
(0.68%) $79.54
Gas
(2.28%) $1.976
Gold
(-0.16%) $2 307.40
Silver
(-1.21%) $26.43
Platinum
(0.27%) $957.50
USD/EUR
(0.16%) $0.934
USD/NOK
(0.52%) $11.09
USD/GBP
(0.07%) $0.799
USD/RUB
(-1.52%) $91.84

Actualizaciones en tiempo real para Microbix Biosystems Inc [MBX.TO]

Bolsa: TSX Industria: Biotechnology
Última actualización1 may 2024 @ 10:42

-1.45% $ 0.340

Live Chart Being Loaded With Signals

Commentary (1 may 2024 @ 10:42):

Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally...

Stats
Volumen de hoy 1 500.00
Volumen promedio 76 504.00
Capitalización de mercado 46.43M
EPS $0 ( 2024-02-14 )
Próxima fecha de ganancias ( $0 ) 2024-05-08
Last Dividend $0.275 ( 1999-09-02 )
Next Dividend $0 ( N/A )
P/E 11.33
ATR14 $0 (0.00%)

Microbix Biosystems Inc Correlación

10 Correlaciones Más Positivas
10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Microbix Biosystems Inc Finanzas

Annual 2023
Ingresos: $16.51M
Beneficio Bruto: $7.48M (45.30 %)
EPS: $-0.000300
FY 2023
Ingresos: $16.51M
Beneficio Bruto: $7.48M (45.30 %)
EPS: $-0.000300
FY 2022
Ingresos: $19.08M
Beneficio Bruto: $11.12M (58.32 %)
EPS: $0.0132
FY 2021
Ingresos: $18.59M
Beneficio Bruto: $11.04M (59.40 %)
EPS: $0.0280

Financial Reports:

No articles found.

Microbix Biosystems Inc Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Microbix Biosystems Inc Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 3.34 - No dividend growth expected in the near future
Information
First Dividend $0.275 1999-09-02
Last Dividend $0.275 1999-09-02
Next Dividend $0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 1 --
Total Paid Out $0.275 --
Avg. Dividend % Per Year 0.00% --
Score 2.33 --
Div. Sustainability Score 10.00
Div.Growth Potential Score 3.34
Div. Directional Score 7.72 --
Next Divdend (Est)
(2024-05-02)
$0 Estimate 0.00 %
Dividend Stability
0.00 Very Bad
Dividend Score
2.33
Pay Frequency
Insufficient data to determine frequency
Yearly Payout
Year Amount Yield
1999 $0 0.00%
2000 $0 0.00%
2001 $0 0.00%
2002 $0 0.00%
2003 $0 0.00%
2004 $0 0.00%
2005 $0 0.00%
2006 $0 0.00%
2007 $0 0.00%
2008 $0 0.00%
2009 $0 0.00%
2010 $0 0.00%
2011 $0 0.00%
2012 $0 0.00%
2013 $0 0.00%
2014 $0 0.00%
2015 $0 0.00%
2016 $0 0.00%
2017 $0 0.00%
2018 $0 0.00%
2019 $0 0.00%
2020 $0 0.00%
2021 $0 0.00%
2022 $0 0.00%
2023 $0 0.00%
2024 $0 0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for TSX

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
XDUH.TO Dividend Knight 2023-08-25 Monthly 7 1.47%
PLC.TO Dividend Knight 2023-06-29 Bi-Monthly 14 0.77%
EXE.TO Dividend King 2023-09-28 Monthly 13 4.13%
ZRE.TO Dividend Knight 2023-08-29 Monthly 15 2.60%
TLF.TO Dividend King 2023-08-30 Monthly 13 3.15%
L-PB.TO Dividend King 2023-09-14 Quarterly 10 3.24%
CMAR.TO Dividend Knight 2023-09-22 Monthly 5 2.05%
XLB.TO Dividend Knight 2023-08-25 Monthly 19 1.89%
PZA.TO Dividend Royal 2023-09-28 Monthly 20 4.10%
FM.TO Dividend Junior 2023-08-25 Semi-Annually 20 0.32%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.1571.5006.8710.00[0 - 0.5]
returnOnAssetsTTM0.09571.2006.818.17[0 - 0.3]
returnOnEquityTTM0.1441.5009.5210.00[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM8.530.80010.008.00[1 - 3]
quickRatioTTM5.990.80010.008.00[0.8 - 2.5]
cashRatioTTM4.601.50010.0010.00[0.2 - 2]
debtRatioTTM0.164-1.5007.27-10.00[0 - 0.6]
interestCoverageTTM5.121.0009.219.21[3 - 30]
operatingCashFlowPerShareTTM0.007022.0010.0010.00[0 - 30]
freeCashFlowPerShareTTM0.0002742.0010.0010.00[0 - 20]
debtEquityRatioTTM0.221-1.5009.12-10.00[0 - 2.5]
grossProfitMarginTTM0.5581.0004.034.03[0.2 - 0.8]
operatingProfitMarginTTM0.2001.0008.018.01[0.1 - 0.6]
cashFlowToDebtRatioTTM0.1591.000-0.226-0.226[0.2 - 2]
assetTurnoverTTM0.6110.8009.267.41[0.5 - 2]
Total Score12.10

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM13.221.0008.770[1 - 100]
returnOnEquityTTM0.1442.509.6910.00[0.1 - 1.5]
freeCashFlowPerShareTTM0.0002742.0010.0010.00[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM0.007022.0010.0010.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM0.1071.500-2.620[0.5 - 2]
operatingCashFlowSalesRatioTTM0.04271.000-1.4310[0.1 - 0.5]
Total Score3.34

Microbix Biosystems Inc

Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. It manufactures a range of critical biological materials for the diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment and proficiency (QAPs) that support clinical lab proficiency testing, assay development and validation, or clinical lab workflows. The company also applies its biological expertise and infrastructure to develop other proprietary products, primarily viral transport medium (DxTM) to stabilize patient samples for lab-based testing and Kinlytic Urokinase, a biologic thrombolytic drug used to treat blood clots. It sells QAPs to lab accreditation organizations, diagnostics companies, and clinical labs through a network of regional distributors. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.

Acerca de Señales en Vivo

Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.

Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico